Paper Details

Paper Title

A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195.

Paper Journal Title

Invest New Drugs

Paper Citation Count

Paper Publication Year

2015

Bio Mention

Mesh Descriptor

Column Actions